Search Results - "LAKATOS, P"

Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid by Reid, I. R., Gamble, G. D., Mesenbrink, P., Lakatos, P., Black, D. M.

“…Context: Intravenous aminobisphosphonates often cause an acute-phase response (APR), but the precise components of this, its frequency, and the risk factors…”
Get full text

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target by Peyrin-Biroulet, L, Sandborn, W, Sands, B E, Reinisch, W, Bemelman, W, Bryant, R V, D'Haens, G, Dotan, I, Dubinsky, M, Feagan, B, Fiorino, G, Gearry, R, Krishnareddy, S, Lakatos, P L, Loftus, Jr, E V, Marteau, P, Munkholm, P, Murdoch, T B, Ordás, I, Panaccione, R, Riddell, R H, Ruel, J, Rubin, D T, Samaan, M, Siegel, C A, Silverberg, M S, Stoker, J, Schreiber, S, Travis, S, Van Assche, G, Danese, S, Panes, J, Bouguen, G, O'Donnell, S, Pariente, B, Winer, S, Hanauer, S, Colombel, J-F

“…The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory…”
Get full text

Neural mechanisms of mismatch negativity dysfunction in schizophrenia by Lee, M, Sehatpour, P, Hoptman, M J, Lakatos, P, Dias, E C, Kantrowitz, J T, Martinez, A M, Javitt, D C

“…Schizophrenia is associated with cognitive deficits that reflect impaired cortical information processing. Mismatch negativity (MMN) indexes pre-attentive…”
Get full text

Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release by Geda, Orsolya, Tábi, Tamás, Lakatos, Péter P., Szökő, Éva

“…Gangliosides are glycosphingolipids of the plasma membrane and are highly enriched in the nervous system where they play a vital role in normal cell functions…”
Get full text

Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle by Restellini, S, Lakatos, P L

Get full text

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort by Burisch, J, Pedersen, N, Čuković-Čavka, S, Brinar, M, Kaimakliotis, I, Duricova, D, Shonová, O, Vind, I, Avnstrøm, S, Thorsgaard, N, Andersen, V, Krabbe, S, Dahlerup, J F, Salupere, R, Nielsen, K R, Olsen, J, Manninen, P, Collin, P, Tsianos, E V, Katsanos, K H, Ladefoged, K, Lakatos, L, Björnsson, E, Ragnarsson, G, Bailey, Y, Odes, S, Schwartz, D, Martinato, M, Lupinacci, G, Milla, M, De Padova, A, D'Incà, R, Beltrami, M, Kupcinskas, L, Kiudelis, G, Turcan, S, Tighineanu, O, Mihu, I, Magro, F, Barros, L F, Goldis, A, Lazar, D, Belousova, E, Nikulina, I, Hernandez, V, Martinez-Ares, D, Almer, S, Zhulina, Y, Halfvarson, J, Arebi, N, Sebastian, S, Lakatos, P L, Langholz, E, Munkholm, P

“…The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe. The reasons for these changes remain unknown. The aim of this study was to…”
Get more information

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study by Papapoulos, S., Lippuner, K., Roux, C., Lin, C. J. F., Kendler, D. L., Lewiecki, E. M., Brandi, M. L., Czerwiński, E., Franek, E., Lakatos, P., Mautalen, C., Minisola, S., Reginster, J. Y., Jensen, S., Daizadeh, N. S., Wang, A., Gavin, M., Libanati, C., Wagman, R. B., Bone, H. G.

“…Summary The FREEDOM study and its Extension provide long-term information about the effects of denosumab for the treatment of postmenopausal osteoporosis…”
Get full text

Separation of tolperisone and its degradation products by a dual cyclodextrin capillary electrophoresis system to study their potential role in allergic events by Lakatos, Péter P., Ignáth, Zsuzsanna, Csernák, Orsolya, Boldizsár, Imre, Szökő, Éva, Tábi, Tamás

“…Tolperisone is a centrally acting muscle relaxant that has been used for the treatment of post-stroke spasticity and low back pain. Recently, the safety of…”
Get full text

The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action by Lakatos, Péter P., Karádi, Dávid Árpád, Galambos, Anna Rita, Essmat, Nariman, Király, Kornél, Laufer, Rudolf, Geda, Orsolya, Zádori, Zoltán S., Tábi, Tamás, Al-Khrasani, Mahmoud, Szökő, Éva

“…Current treatment approaches to manage neuropathic pain have a slow onset and their use is largely hampered by side-effects, thus there is a significant need…”
Get full text

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats by Karádi, David Á, Galambos, Anna Rita, Lakatos, Péter P, Apenberg, Joost, Abbood, Sarah K, Balogh, Mihály, Király, Kornél, Riba, Pál, Essmat, Nariman, Szűcs, Edina, Benyhe, Sándor, Varga, Zoltán V, Szökő, Éva, Tábi, Tamás, Al-Khrasani, Mahmoud

“…Despite the large arsenal of analgesic medications, neuropathic pain (NP) management is not solved yet. Angiotensin II receptor type 1 (AT1) has been…”
Get full text

Time to onset of bisphosphonate‐related osteonecrosis of the jaws: a multicentre retrospective cohort study by Fung, PPL, Bedogni, G, Bedogni, A, Petrie, A, Porter, S, Campisi, G, Bagan, J, Fusco, V, Saia, G, Acham, S, Musto, P, Petrucci, MT, Diz, P, Colella, G, Mignogna, MD, Pentenero, M, Arduino, P, Lodi, G, Maiorana, C, Manfredi, M, Hallberg, P, Wadelius, M, Takaoka, K, Leung, YY, Bonacina, R, Schiødt, M, Lakatos, P, Taylor, T, De Riu, G, Favini, G, Rogers, SN, Pirmohamed, M, Nicoletti, P, Fedele, S, López‐Cedrún, Jose L, Madsen, Sanne, Sadile, Gennaro, Leuci, Stefania, Mirelli, Cristina, Conti, Giulio, Maiavacca, Rita, Urade, Masahiro, Kishimoto, Hiromitsu, Okui, Shin, Zushi, Yusuke, Yamamura, Michiyo, Yoshikawa, Kyohei, Mansueto, Giovanna, Magnusson, Patrik KE, Popat, Shina, Kirnbauer, Barbara, Obermayer‐Pietsch, Barbara, Jakse, Norbert, Mariani, Umberto, Martini, Valeria, Fasciolo, Antonella, Martino, Iolanda, Alessio, Manuela, Sanromán, Jacinto F, Grammatico, Sara, Siniscalchi, Giovanni, Itro, Angelo, Balla, Bernadett, Kosa, Janos P, Vaszilko, Mihaly, Lo, John, Besi, Eleni, D'Aiuto, Francesco, Yong, Kwee, Donos, Nikos, Mercadante, Valeria, Stein, Robert, D'Sa, Shirley, Varoni, Elena, Soma, Damiano, Meloni, Silvio, Evely, Jane, Hanson, Anita, Giancola, Francesco, Di Fede, Olga, Panzarella, Vera, Bettini, Giordana, Merigo, Elisabetta, Mergoni, Giovanni, Vescovi, Paolo, Gandolfo, Sergio, Marino, Roberto, Berrone, Mattia, Gambino, Alessio, Menegatti, Elisa, Broccoletti, Roberto, Hens, Elena, Bagan, Leticia

“…Objectives Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of bisphosphonates (BP). Although the risk of ONJ increases with increasing…”
Get full text

Review article: the natural history of paediatric‐onset ulcerative colitis in population‐based studies by Fumery, M., Duricova, D., Gower‐Rousseau, C., Annese, V., Peyrin‐Biroulet, L., Lakatos, P. L.

“…Summary Background A better knowledge of the natural history of disabling chronic diseases is essential to improve patient management, evaluate the impact of…”
Get full text

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease by Kiss, L. S., Szamosi, T., Molnar, T., Miheller, P., Lakatos, L., Vincze, A., Palatka, K., Barta, Z., Gasztonyi, B., Salamon, A., Horvath, G., Tóth, G. T., Farkas, K., Banai, J., Tulassay, Z., Nagy, F., Szenes, M., Veres, G., Lovasz, B. D., Vegh, Z., Golovics, P. A., Szathmari, M., Papp, M., Lakatos, P. L.

“…Aliment Pharmacol Ther 2011; 34: 911–922 Summary Background  Adalimumab is a fully human monoclonal antibody targeting tumour necrosis factor with proven…”
Get full text

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy by Molnár, T., Lakatos, P. L., Farkas, K., Nagy, F., Szepes, Z., Miheller, P., Horváth, G., Papp, M., Palatka, K., Nyári, T., Bálint, A., Lőrinczy, K., Wittmann, T.

“…Summary Background Some of the most important questions relating to the use of biological therapy in inflammatory bowel diseases concern the duration of…”
Get full text

Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD? by Lakatos, P L, Miheller, P

“…Tumour necrosis factor alpha (TNF-alpha) inhibitors ensure valuable treatment advantages for patients with inflammatory bowel diseases (IBD) by offering a more…”
Get more information

Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model by Mohammadzadeh, Amir, Lakatos, Péter P, Balogh, Mihály, Zádor, Ferenc, Karádi, Dávid Árpád, Zádori, Zoltán S, Király, Kornél, Galambos, Anna Rita, Barsi, Szilvia, Riba, Pál, Benyhe, Sándor, Köles, László, Tábi, Tamás, Szökő, Éva, Harsing, Jr, Laszlo G, Al-Khrasani, Mahmoud

“…The limited effect of current medications on neuropathic pain (NP) has initiated large efforts to develop effective treatments. Animal studies showed that…”
Get full text

Predictive suppression of cortical excitability and its deficit in schizophrenia by Lakatos, Peter, Schroeder, Charles E, Leitman, David I, Javitt, Daniel C

“…Recent neuroscience advances suggest that when interacting with our environment, along with previous experience, we use contextual cues and regularities to…”
Get full text

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis by Black, Dennis M, Delmas, Pierre D, Eastell, Richard, Reid, Ian R, Boonen, Steven, Cauley, Jane A, Cosman, Felicia, Lakatos, Péter, Leung, Ping Chung, Man, Zulema, Mautalen, Carlos, Mesenbrink, Peter, Hu, Huilin, Caminis, John, Tong, Karen, Rosario-Jansen, Theresa, Krasnow, Joel, Hue, Trisha F, Sellmeyer, Deborah, Eriksen, Erik Fink, Cummings, Steven R

“…In this double-blind, placebo-controlled trial, women with postmenopausal osteoporosis received an infusion of either zoledronic acid (5 mg) or placebo at…”
Get full text

The effect of L-theanine and S-ketamine on d-serine cellular uptake by Lakatos, Péter P., Vincze, István, Nyariki, Noel, Bagaméry, Fruzsina, Tábi, Tamás, Szökő, Éva

“…Decreased extracellular level of d-Serine (D-Ser), a co-agonist of the N-methyl-d-aspartate (NMDA) receptors was connected to receptor hypofunction in the…”
Get full text

Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats by Essmat, Nariman, Galambos, Anna Rita, Lakatos, Péter P, Karádi, Dávid Árpád, Mohammadzadeh, Amir, Abbood, Sarah Kadhim, Geda, Orsolya, Laufer, Rudolf, Király, Kornél, Riba, Pál, Zádori, Zoltán S, Szökő, Éva, Tábi, Tamás, Al-Khrasani, Mahmoud

“…The current treatment of neuropathic pain (NP) is unsatisfactory; therefore, effective novel agents or combination-based analgesic therapies are needed…”
Get full text